WORKSHOP organised by DGXI and the German Federal Ministry of the Environment, Nature Conservation and Nuclear Safety Cordoba, Spain, January 15, 16 1998 Attended on behalf of the WFCC by Barbara Kirsop, Chair WFCC Biodiversity Committee, with sponsorship by the Workshop Organisers A background document had been prepared by 3 authors at Bonn, Germany, and this was generally accepted by the participants, with some minor changes. A draft Summary and Recommendations document was also distributed, but this was considerably revised following discussions by participants. On the second day of the workshop the group divided into 'users' and 'providers' and considered the uncertainties of each with regard to access and benefit sharing (ABS) and recommendations to COP4 regarding resolving the uncertainties. The Workshop output will be provided to COP4 for its consideration (Bratislava, 1998). BK will find out when the documents can be made publically available and will ensure that they are transmitted to WFCC as soon as possible. This may not be until after the Parties to the Convention have received them. The WFCC InfoDoc was distributed to all participants and other WFCC material also. -------------------------------------------------------------- COMMENTS The Workshop participants were from botanical gardens, universities and industry. The emphasis was on commercial use because this is where 'access and benefit sharing (ABS)' issues are most relevant (but see below). - Microorganisms seemed to be high on the agenda once more. There was discussion about natural products v combinatorial chemistry and people generally felt that the natural products were always likely to be required for industry and certainly, of course, for other uses (research, education). - There was some discussion about the ubiquity of microorganisms, and some misunderstanding. BK was able to point out the uncertainties of reisolation, the importance of the strain, the rapid generation times, the loss of some strains that only occurred in habitats now lost etc etc. Much of this as written in the WFCC InfoDoc. - Although much of the workshop emphasis was on the industrial use of microorganisms, since this is where monetary benefit sharing is most likely to occur, BK and others emphasised that there were other 'users' with other 'benefits' to be shared and the free exchange of research/educational material was vital to preserve and mechanisms have to be introduced to make this happen. This is generally accepted, and one of the Recommendations put forward was that the different kinds of users be recognised by PArties to the CBD and their different needs addressed, ie users are not only commercial, benefits are not only monetary. It is good that this is being dsicussed. - Although mostly at such meetings there is discussion about botanical gardens and not CCs, the term 'ex-situ providers' was introduced as one that would include microbial resource centres. Maybe WFCC can begin to use this term in CBD meetings etc. - The need to track movement of microbial resources that pass through the 'intermediaries' (ie ex-situ providers) was raised by BK as, without this, there is no record of the country of origin, the collection number, the recipient(s) etc, and therefore CCs could not comply with the CBD when cultures are supplied. This mechanism has to be very simple, not an administrative burden (as we have discussed in WFCC circles). BK explained how various groups were beginning to consider how this can best be done (WFCC, MOSAICC, UK CCs etc). The concept of tracking was strongly opposed by industry. In the case where a company has an agreement with a single provider Institute, all parties know exactly where/what was being transferred and a tracking mechanism is indeed not required. This is a specific situation. However, industry seems not to understand that there are also many other categories of providers/users where movement of resources is not so defined. For example, the world's CCs are distributing hundreds of resources daily and this is a quite different situation and we need to devise mechanisms that suit the needs and capabilities of the ex-situ providers. There was concern by industry that Universities may be 'passing on' strains to 3rd parties inadvertantly (or deliberately). BK felt that a simple tracking mechanism (for eg a Form that followed the transfer of any resource) could help this situation also since a resource could not finally be developed unless the associated Transfer Document was also available to prove its origins. This clearly needs thinking through among WFCC and other groups. The CITES system already uses such a tracking mechanism and it seems that it works well. - BK had a good discussion with Professor Zakri, Malaysia, now Chair SBSTTA. He was interested in the case of microorganisms and wonders whether he should suggest to SBSTTA the formation of a Focus Group for microorganisms. BK suggested that this could be very helpful in resolving the current uncertainties, finding solutions, developing mechanisms etc. - There was discussion about the present IPR system, and the need to develop alternative lower cost systems for DCs. On the whole it was felt that this complex issue was not appropriate for discussion by the workshop. The final Recommendations include a list of uncertainties felt by users and providers and that need to be addressed by COP4. Some of these are listed below, in no order of importance: Users uncertainties included: need for clear contact points and competant authorities in countries; clarity of legal rights over resources; need for corporate ABS policies; lack of legal and negotiating experience in provider countries. ....... Provider uncertainties included: need to establish a mechanism to provide evidence of prior informed consent; value of resources; lack of control once resources outside area of providers' jurisdiction (hence need for tracking system); need to clarify position regarding non-commercial use; lack of confidence, especially re IPRs; lack of negotiating experience and knowledge of market structure for genetic resources. Recommendations to COP will ask that some of these uncertainties are addressed. SUMMARY It is good that the situation regarding microorganisms is better understood now; also the needs of the different user communities is being recognised (ie research/teaching). It could be useful if some Parties (Countries) are encouraged to ask COP that these uncertainties be resolved and maybe WFCC members can put this forward to their national delegates for COP4. (It seems that the Philippines well recognises research needs and the legal departments are using scientists in an advisory capacity to ensure these needs are not impaired). The commercial ABS issues seem to be more in perspective now and expectations not so high. Companies are developing access policies and trying to find the best regions to collaborate with (ie those with well defined procedures that are flexible). This workshop was encouraging for WFCC in that participants seem increasingly attuned to microbiological issues; no measures were discussed that adversely affect our activities and aims. We need to continue to ensure that the message is spread to our governments and others at all opportunities.